Pharming Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	954	627	690	707	503	812
Market Cap Growth	60.79%	-9.08%	-2.41%	40.66%	-38.05%	-17.99%
Enterprise Value	924	587	658	657	487	787
Last Close Price	1.39	0.93	1.03	1.08	0.78	1.27
PE Ratio	2931.43	-	-	55.27	35.75	26.30
Forward PE	64.79	-	163.65	27.10	16.92	15.76
PS Ratio	3.09	2.19	3.11	3.68	2.88	4.68
PB Ratio	4.23	2.94	3.49	3.69	2.96	5.41
P/TBV Ratio	8.63	4.06	5.17	5.82	5.23	10.47
P/FCF Ratio	21.24	-	-	35.85	21.10	12.57
P/OCF Ratio	21.00	-	-	33.66	15.11	11.87
EV/Sales Ratio	2.99	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	21.47	188.69	-	40.97	18.22	11.66
EV/EBIT Ratio	26.65	-	-	67.70	23.07	12.62
EV/FCF Ratio	20.57	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.50	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	2.55	17.02	-	8.46	4.88	1.92
Debt / FCF Ratio	2.48	-	-	7.91	5.97	2.05
Net Debt / Equity Ratio	-0.13	-0.25	-0.19	-0.20	-0.16	-0.24
Net Debt / EBITDA Ratio	-0.74	-17.24	2.74	-2.37	-0.99	-0.52
Net Debt / FCF Ratio	-0.67	21.50	2.24	-1.93	-1.11	-0.55
Asset Turnover	0.81	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.57	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.39	2.96	3.28	3.90	4.69	3.09
Current Ratio	3.16	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	0.03%	-5.38%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	5.76%	-0.52%	-3.06%	1.57%	3.68%	14.13%
Return on Invested Capital (ROIC)	0.08%	-2.10%	-12.76%	5.79%	10.98%	54.07%
Return on Capital Employed (ROCE)	10.70%	-1.10%	-5.70%	2.80%	6.80%	22.30%
Earnings Yield	0.03%	-1.82%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	4.71%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	2.65%	-2.18%	7.09%	-0.85%	-2.70%	-1.37%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.